Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Golden star on black background - award photo.

Marieke Oudelaar portrait photo

Dr Marieke Oudelaar, a Junior Research Fellow from the Higgs Group and Hughes Group, has been awarded one of the prestigious Lise Meitner Excellence Program grants - a new initiative from the Max Planck Society to recruit and promote exceptionally qualified female scientists. The grants are awarded to researchers at a very early stage in their scientific careers who are future stars within their field.

In recent years at the MRC WIMM, Marieke’s research has focused on the mechanisms by which regulatory elements of the genome control tissue-specific gene expression patterns. Marieke will start her own independent research group in the Max Planck Institute for Biophysical Chemistry in Göttingen. We congratulate her on this award and wish her the best of luck in her new venture.

Similar stories

Wellcome Trust funding success for Jim Hughes and James Davies

£3.6 million in funding awarded by the Wellcome Trust to combine cutting-edge 3D genome technologies with machine learning approaches to decipher the role of the non-coding genome in disease.

Fundraising for award in memory of Dr Ling Felce

The Ling Felce award will promote cross-disciplinary excellence in bioinformatics.

Study of T-cell receptor activation leads to surprising discovery

A study from Davis Group is the first to describe the structure of the T-cell receptor when bound to an activating ligand. The findings shed light on an important trigger in the immune system, and suggest a completely new process by which cell receptors can be activated.

Biotech spinout MiroBio acquired by Gilead Sciences for ~£332m

Co-founded by Prof. Simon Davis, MiroBio focuses on developing therapeutics for inflammatory diseases.

Seven research groups secure LEAF Sustainability Awards

The Laboratory Efficiency Assessment Framework (LEAF) aims to support research groups to embed sustainability into their work.